Stay updated on ARO-APOC3 in Dyslipidemia Clinical Trial
Sign up to get notified when there's something new on the ARO-APOC3 in Dyslipidemia Clinical Trial page.

Latest updates to the ARO-APOC3 in Dyslipidemia Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now shows Revision: v3.4.2, and the previous items 'Notice Because of a lapse in government funding...' and 'Revision: v3.4.1' have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedA government funding lapse notice is now displayed at the top of the page. The site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded Show glossary and updated metadata to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Replaced the previous indicators 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a broad list of trial locations across the United States, Australia, Canada, and New Zealand, and updated the study status to Completed. These changes reflect the open-label extension and expanded site participation.SummaryDifference2%

- Check91 days agoChange DetectedRevision: v3.3.2 is displayed on the page, replacing v3.2.0.SummaryDifference0.0%

Stay in the know with updates to ARO-APOC3 in Dyslipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in Dyslipidemia Clinical Trial page.